Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.hcplive.com/view/guillain-barr-syndrome-linked-to-ad26-cov2-s-covid-19-vaccine
0
0
Guillain-Barré Syndrome Linked to Ad26.COV2.S COVID-19 Vaccine - MD Magazine
2/3/23 at 9:00pm
Organization
Hcplive.com
Author
Giuliana Grossi
Details
32 words
Summarize
Health
Neurological Conditions
Guillain--Barré Syndrome
mRNA
Moderna
BNT162b2
The mRNA vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) showed no risk of Guillain-Barré syndrome post-vaccination.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...